BIONET Corp. (TPEX: 1784)
Taiwan
· Delayed Price · Currency is TWD 103.00
0.00 (0.00%)
Sep 11, 2024, 10:10 AM CST
BIONET Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 62.74 | 78.4 | 37.97 | 26.62 | 12.74 | 6.8 | Upgrade
|
| Depreciation & Amortization | 33.33 | 32.28 | 34.38 | 31.16 | 34.01 | 40.67 | Upgrade
|
| Other Amortization | 7.22 | 7.32 | 8.67 | 7.68 | 4.05 | 1.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | -0.01 | 0.03 | 0.04 | 1.23 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.79 | -2.63 | 5.35 | -0.21 | 4.17 | -3.31 | Upgrade
|
| Stock-Based Compensation | 9.01 | 4.99 | - | 2.44 | 0.22 | 0.48 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.57 | 1.6 | 3.14 | 0.33 | 0.81 | 0.64 | Upgrade
|
| Other Operating Activities | -2.77 | 19.48 | 25.28 | 12.3 | -8.21 | 10.01 | Upgrade
|
| Change in Accounts Receivable | -3.08 | -30.56 | -67.44 | -74.97 | -8.22 | 10.6 | Upgrade
|
| Change in Inventory | -23.04 | -8.84 | 32.65 | 1.02 | 20.2 | -3.25 | Upgrade
|
| Change in Accounts Payable | 10.19 | 9.74 | 1.34 | 19.94 | -8.7 | 19.44 | Upgrade
|
| Change in Unearned Revenue | 60.04 | 37.35 | 23.33 | 2.32 | -13.78 | -10.64 | Upgrade
|
| Change in Other Net Operating Assets | -15.33 | 14.87 | 29.83 | -17.58 | 3.23 | -29.93 | Upgrade
|
| Operating Cash Flow | 145.43 | 153.1 | 94.65 | 13.88 | 73.66 | 2.67 | Upgrade
|
| Operating Cash Flow Growth | 26.07% | 61.74% | 582.04% | -81.16% | 2659.84% | - | Upgrade
|
| Capital Expenditures | -64.15 | -20.04 | -28.87 | -10.17 | -26.83 | -11.6 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | 0.01 | - | - | 0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -5.16 | -6.24 | -4.04 | -6.49 | -11.21 | -5.54 | Upgrade
|
| Investment in Securities | -476.95 | -383.26 | 30.43 | 13.14 | 40.31 | 45.18 | Upgrade
|
| Other Investing Activities | -4.2 | -0.39 | -0.44 | -1.06 | -0.25 | 22.05 | Upgrade
|
| Investing Cash Flow | -550.45 | -409.93 | -2.91 | -4.59 | 2.03 | 50.1 | Upgrade
|
| Short-Term Debt Issued | - | 30 | - | - | - | - | Upgrade
|
| Total Debt Issued | 65 | 30 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -8.03 | -7.61 | -7.1 | -6.66 | -13.99 | Upgrade
|
| Net Debt Issued (Repaid) | 56.11 | 21.97 | -7.61 | -7.1 | -6.66 | -13.99 | Upgrade
|
| Issuance of Common Stock | 7.29 | 6.7 | - | 7.18 | 4.42 | 4.73 | Upgrade
|
| Repurchase of Common Stock | -1.37 | - | -41.25 | -6.66 | - | -24.92 | Upgrade
|
| Common Dividends Paid | -32.63 | -32.63 | -23.52 | -8.77 | -5.94 | -13.32 | Upgrade
|
| Other Financing Activities | 652.13 | 337.93 | 20.48 | -0.25 | -17.63 | -22.17 | Upgrade
|
| Financing Cash Flow | 681.53 | 333.98 | -51.9 | -15.6 | -25.81 | -69.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.23 | -0.27 | -0.03 | -0.26 | -0.46 | -0.21 | Upgrade
|
| Net Cash Flow | 276.74 | 76.88 | 39.82 | -6.56 | 49.42 | -17.11 | Upgrade
|
| Free Cash Flow | 81.29 | 133.05 | 65.78 | 3.71 | 46.83 | -8.93 | Upgrade
|
| Free Cash Flow Growth | -15.66% | 102.27% | 1674.48% | -92.08% | - | - | Upgrade
|
| Free Cash Flow Margin | 6.99% | 11.80% | 6.71% | 0.40% | 5.81% | -1.15% | Upgrade
|
| Free Cash Flow Per Share | 1.71 | 2.81 | 1.39 | 0.08 | 0.98 | -0.19 | Upgrade
|
| Cash Interest Paid | 0.71 | 0.41 | 0.46 | 0.39 | 0.33 | 0.61 | Upgrade
|
| Cash Income Tax Paid | 23.6 | 9.06 | 6.75 | 3.48 | 2.09 | 8.08 | Upgrade
|
| Levered Free Cash Flow | -69.83 | 70.21 | 32 | 135.63 | 41.31 | 21.48 | Upgrade
|
| Unlevered Free Cash Flow | -69.39 | 70.47 | 32.29 | 135.87 | 41.52 | 21.86 | Upgrade
|
| Change in Net Working Capital | 85.28 | 0.77 | 13.37 | -91.75 | -43.65 | 8.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.